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Silent myocardial ischemia isa frequent and prognostically 
significani feature of patients with coronary artery disease. 
The outcome of patients after myocardial infarction is 
strongly dependent on residual left ventricular function, the 
extent of coronary artery disease and the presence ofrecur- 
rent ischemia. Previous tudies (I ,2) of patients after myo- 
cardial infarction in the prethrombolytic era have shown an 
association between ST segment depression detected on 
Holter monitoring and unfavorable prognosis. However, the 
specific pathophysiologic mechanisms linking ST segment 
depression tounfavorable outcome after myocardial infarc- 
tion and the influence of thrombolytic treatment on ST 
segment shift in these patients are unknown and deserve 
exploration. Accordingly, we studied Holter monitoring- 
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detected ST segment depression among 115 patients who 
were part of a previously reported (3) randomized, ouble- 
blind, placebo-controlled study of recombinant tissue-type 
plasminogen activator in patients with acute myocardial 
infarction. We hypothesized that detection of ST segment 
shift would identify those patients with more severe coro- 
nary artery disease and left ventricular dysfunction, as well 
as an unfavorable prognosis. 
StudY patients. Patients tudied were part of a random- 
ized, placebo-controlled, double-blind trial investigating the 
efficacy and safety of double-chain recombinant tissue-type 
plasminogen activator ( t-PA, Burroughs Wellcome Co.) in 
the management of acute myocardial infarction. The details 
of treatment and study protocol have been published else- 
where (3). Patients enrolled were ~75 years of age, present- 
ing within 13.75 h from the onset of ischemic hest pain. 
Patients were excluded if they had cardiogenic shock, left 
bundle branch block, prior aortocoronary b pass urgery or 
recent (<I month) percutaneous transluminal coronary an- 
gioplasty, obvious contraindications to thrombol 
or an inability to provide informed consent. 
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infarction was defined by the presence oftypical chest Pain, 
ST segment elevation ~0.1 mV in two contiguous leads and 
an increase intotal creatine kinase 2 I .5 times the upper limit 
of normal. Eligible patients (n = 115) were randomized to
either t-PA or matching placebo, and all received intrave- 
nous heparin for 96 h followed by aspirin, 325 mglday (3). 
Molter monitoring. Two-channel ( eads VS and aVF) 
Holter monitoring (Marquette Electronics) was performed 
on days 4 and 7 after admission of patients to the hospital. 
Significant ST segment depression was defined as a transient 
downward or horizontal displacement of the ST segment 
~0. I mV below baseline or ~0.2 mV if baseline ST segment 
level was ~0, I mV, The ST segment level was measured at
$0 ms after the J point, and the episodes of ST segment 
depression had to be 81 min and separated from other 
I min. ST segment depression was identified 
by an automated algorithm and all episodes were reviewed 
by three independent and experienced observers who were 
unaware of the results of other tests: the differences were 
ted by consensus. 
e&e testing. All patients uaderwent symptom-limited 
exercise testing on day 8 according to the Bruce protocol. 
The IZlead electrocardiogram (ECG) was recorded at base- 
line and at I-min intervals. Significant ST segment depres- 
sion was considered to be 20.1 mV below baseline. The 
exercise results were interpreted by an independent ob- 
server unaware of the results of other tests. 
Assessment of left ventricular function. Left ventricular 
function was assessed with radionuclide v ntriculography on 
day 9. Studies were acquired in the anterior, 45” left anterior 
oblique and 70” left anterior oblique views with the use of 
multigated acquisition of32 frames/cardiac cy le after mod- 
ified in vivo labeling of red blood cells with 30 mCi of 
technetium-99m. 
Global left ventricular ejection fraction was calculated 
with the use of a semiautomated method for definition of 
end lit and end-systolic regions with calculation of 
bat d from a left paraventricular region of interest. 
Regional ejection fractions in the 45” left anterior oblique 
view were calculated for one inferoapical, two septal and 
two posterolateral segments, each segment encompassing 
60” of the circumference of the ventricle. Assignment of 
infarct-related segments for regional calculations was keyed 
to the qualifying ECG. For anterior infarction, the infero- 
apical and the two septal segments were averaged and for 
inferior infarction, the inferoapical nd the two posterolat- 
era) segments were averaged to give the regional ejection 
fraction in the area of infarction. 
Clinically significant improvement i  left ventricular func- 
tion was judged to be present when a ~5% increase inglobal 
ejection fraction occurred; in our laboratory, in35 patients 
from this study. the variability of the global ejection fraction 
estimate was <3.4%. 
Cenliac atheterization. Cardiac atheterization was per- 
formed according toa predetermined protoccl in I 15 patients 
as described previously (3). For the 47 patients who were 
initially admitted to the three core institutions with facilities 
for cardiac atheterization, a giography was performed at18 
+ 6 h after administration f the study drug. Patency of the 
infarct-related vessel was defined as Thrombolysis in
cardial Infarction (TIMI) perfusion grade 2 or 3, and patients 
with a patent vessel were restudied on day 9 to document the 
reocclusion rate in this subset. The 59 patient> initially 
admitted to a hospital without facilities for catheterization 
were transferred by random assignment toone of the three 
core hospitals on day 4 and underwent coronary angiography 
on day 9 to provide an unbiased estimate of late coronary 
artery patency. Nine additional randomized patients did not 
undergo coronary angiograp y because of patient refusal, 
death, urgent revascularization or an administrative prob- 
lem. 
For the purposes ofthis study only, the results of the day 
9 angiogram were considered because it was more contem- 
poraneous with the performance of radionuchde angiogra- 
phy and J-Jolter monitoring. 
Quantitative coronary angiography of the infarct-related 
artery was performed by an independent laboratory (Univer- 
sity of Minnesota) using a previously described automated 
edge detection algorithm ofthe Coronary Angiography Anal- 
ysis System (4) that was employed to calculate minimal 
cross-sectional area. 
Follow-up. Patients were followed for up to 3 years after 
discharge from the hospital to assess recurrence ofcardiac 
events defined as death or nonfatal reinfarction. 
Statistical analysis. Results are presented as mean value 
5 SD for continuous data and relative frequencies (that is, 
percentages) for categoric data. Comparison ofthe continu- 
ous data between patient groups was performed by using an 
unpaired t test, and in the case of categoric data, by using 
chi-square analysis and the Fisher exact est where applica- 
ble. 
The protocol and consent form were approved by the 
Human Subjects Review Committee of the University of 
Toronto and the Institutional Review Boards of the partici- 
pating hospitals. All patients provided written informed 
consent. 
A total of 115 patients were enrolled and randomized in
the study. Of these, six did not undergo Holter monitoring; 
five died and one patient underwent early percutaneous 
transluminal coronary angioplasty. Of the remaining 109 
patients, 35 (32%) had one or more episodes of ST segment 
depression on either day 4 or day 7 with all except one 
episode being asymptomatic; the mean number of episodes 
was 3.1 2 2.6 (range 1to 13) with a mean duration of 36.8 t
37.3 min. There was no difference inthe number of episodes 
or duration of ST segment depression between day 4 and day 
7 of Holter monitoring. A comparison ofpatients with and 
without ST segment depression (Table 1) did not reveal 
significant differences in clinical characteristics or propor- 
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le 1. Clinical characteristics 
No ST 
ST Segment Segment 
Depression De+rPGon 
(n = 35) (n = 74) p Value 
Age (yr) 56 r 10 57 +- liJ_ 0.8 
Men/women (n) 3213 5905 0.12 
Hypertension (%) 29% 38% 0.34 
Previous MI (%) 9% 8% 1.0 
Q waves 0.1 discharge WC (%) 89% 88% I.0 
Anterior MP (%) 51% 32% 0.06 
r&PA/placebo (n) 21114 3.5139 0.2 
CK max (1Ulliter) 1.530 + 969 1,546 + 1,011 0.9 
CK MB max (W/liter) 45 ” 30 45 ? 21 1.0 
Unless otherwise indicated. data are presented as mean value + SD. CK 
= creatine kinase; CK MB = creatine kinase. MB fraction; ECG = electro- 
cardiogram; max = maximal; MI = myqcardial infarction: rt-PA = rccombi- 
nanl tissue-type plasminogen activafor. 
each group that received rt- 
Gents with ST seg 
anterior myocardial infarction. 
Recurrent chest ?ain was observed in 51% of patients 
with and 45% of patients without ST segment depression 
(p = 0.8). There was also no difference between the number 
of episodes of recurrent chest pain in patients with and 
without ST segment depression (3.7 k 3.9 vs. 3.2 + 2.8, p = 
0.6). 
Coronary a~giograp~y. Among 109 patients who under- 
went Holter monitoring, 100 underwent coronary angiogra- 
phy; of these, 57 underwent only a day 9 angiogram. 
Forty-three patients had a day 1 angiogram, of whom 33 
were shown to have a patent infarct-related artery: 31 had a 
day 9 angiogram according to protocol an3 2 did not undergo 
a day 9 angiogram for technical reasons. Thus, a total of 88 
patients underwent a day 9 angiogram. 
The mean number of vessels with 250% stenosis was 
similar in patients with and without ST segment depression 
(1.7 L 0.8 vs. 1.5 + 0.8, p = 0.32); there was also no 
difference inthe proportion of patients in these two subsets 
with three-vessel disease (23% vs. 15%), two-vessel disease 
(23% vs. 26%), one-vessel disease (54% vs. 53%) or zero- 
vessel disease (0% vs. 6%, p = 0.5 for all comparisons). 
When all patients with a day 9 angiogram were assessed, 
those with ST segment depression had a significantly smaller 
cross-sectional area of the infarct-related artery than did 
those without ST depression (Table 2). When only patients 
with a patent infarct-related artery were assessed, those with 
ST segment depressiou had a smaller cross-sectional area 
than did those without ST depression (Table 2). There was 
no significant difference between patients with and without 
ST segment depression with respect o reference diameter 
(that is, the normal diameter ofthe inL;ihct-related artery just 
proximal to the culprit lesion) or frequency of complete 
occlusion of the infarct-related artery (Table 2). 
There was no di!Terence b tween patients treated with 
ST No ST 
Segment Segme;lt 
Depression Depression 
(n = 29) (PI = 59) 
Day 9 minimal CSA (mm’) 0.59 + 0.59 1.04 + 1.26 
Complete occlusion (R) 28% 19% 
Day 9 minimal CSA (mm’) in 0.81 t 0.52 1.28 + 1.28 
patients wtth patent IRA 
Reference diameter (mm) 2.04 t 1.64 2.30 ? 1.55 
CSA = cross-sectional area: IRA = infarct-related artery. 
p Value 
0.02- 
0.34 
0.03 
0.45 
A versus placebo w respect to the relation between ST 
segment depression on her monitoring and minimal cross- 
sectional rea. 
found in global ejection fraction betwe 
without ST segment depression o  day 
et-, on day 9, global ejection fraction 
patients with than in those 
vs. 52 k 14%, p = 0.08). 
global eft ventricular function did not ch 
with ST depression (0 k 7%), whereas it i 
cantly from day 1 to day 9 in patients without 
(4 + II%, p < 0.001). Given that anterior myocardial 
rction occurred more frequently in patients with ST 
pression, we performed analysis of covariance to assess 
whether asignificant interaction between occurrence ofST 
depression and the infarct site was evident with respect to 
improvement i  global ejection fraction: no such interaction 
was present (ST depression alone F = 4.4, p < 0.05; infarct 
location alone F = 0.1, p = 0.8; interaction term F = 0.2, 
p = 0.7). 
Comparison of infarct regional ejection fraction between 
patients with and without ST segment depression revealed 
no difference on either day I (33 + 14% vs. 33 + 14%, p = 
0.77) or day 9 (36 2 15% vs. 40 f 15%, p = 0.24). However, 
there was a significant increase in infarct regional ejection 
fraction from day 1 to day 9 in patients with (3 + 6%, p = 
0.01) ST segment depression and in those without (6 t 1 I%, 
p = 0.0001) ST d epression. There was also a trend for a 
greater extent of improvement in infarct regional 
fraction in patients without ST segment depressive ( 
vs. 3 5 6%, p = 0.09). 
A comparison of noninfarct regional ejection fraction 
between patients with and without ST segment depression 
did not reveal an,’ difference on day 1 (38 t 12% vs. 35 + 
9%, p = 0.22) or d.\y 9 (41 + 14% vs. 41 2 13%, p = 0.84). 
However, there W:IS a significant increase in ~o~infarct 
regional ejection fraction from day 1 to day 9 in patients 
without ST segment depression (6 + 12%, p = 0.001): no 
significant increase occurred in patients with ST segment 
depression (2+ 9%, p = 0.2). 
We also evaluated the number of patients in whom left 
ventricular ejection fraction improved from day 1 to day 9 by 
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~5%. This improvement was less frequent among patients 
with as compared with those without ST segment depression 
(23% VS. 52%, p = 0.01). There was a trend for ~-5% 
improvement i  infarct regional ejection fraction to be less 
frequent in patients with as compared with those without ST 
segment depression (39% vs. 57%, p = 0.10); no difference in
this variable was found with respect to noninfarcr regional 
ejection fraction (45% vs. 46%, p = 0.93). 
There was no difference between patients treated with 
and without rt-PA with respect to the relation between ST 
segment depression on Holter monitoring and left ventricu- 
lar function. 
Exercise t sting. The results of exercise testing were first 
studied according to whether patients had ST segment 
depression on Holter monitoring; 31 of 35 patients with 
compared with 68 of 74 patients without ST depression on 
Molter monitoring underwent exercise testing. The duration 
of the exercise test was similar in p:itients with and without 
ST depression o  Holter monitoring (6. I + 2.5 min vs. 6.8 rt 
2.6 min, p = 0.26). Patients with ST segment on Halter 
monitoring tended to have a greater magnitude of ST depres- 
sion during exercise testing (0.18 rt 0.15 mV) than that of 
patients without ST segment depression on Holter monitor- 
ing (0.12 I 0.14 mV, p = 0.08). 
We then studied the relation between recurrence of ST 
segment depression during exercise testing and infarct- 
related artery patency and found that minimal cross- 
sectional rea was similar in patients with positive or nega- 
tive results on exercise testing (0.8 + 0.8 vs. 1.0 rt: 1.4 m’, 
p = 0.36). 
Follow=ug, Comparison of in-hospital events in the 35 
patients with and the 74 patients without ST segment depres- 
sion did not reveal any differences; there were no recurrent 
infarctions and only three deaths, all in patients without ST 
depression. In addition, I7 patients, 6with ST depression 
and 11 without, underwent revascularization (coronary an- 
gioplasty in 13 and bypass urgery in 4). No difference in 
antiawinal therapy was found between patients with and 
without ST depression on Holter monitoring. 
Among 89 patients who were discharged without an 
in-hospital event, 13 were lost to follow-up. In the remaining 
76 patients, the mean follow-up interval of 18 f 11 months 
revealed a greater f equency of death (five patients with ST 
segment depression a d two without) and recurrent myocar- 
dial infarction (two patients with ST depression and one 
without) in patients with ST depression as compared with 
those without (27% vs. 6%, p = 0.03). 
When hospital course and follow-up data were combined, 
there continued to be a twofold increase in death and 
recurrent infarction among patients with ST segment depres- 
sion, although this was not statistically significant (20% vs. 
%, p = 0.17). 
Patients with positive as compared with those with ncg- 
ative 0X&S On exercise: testing had a similar incidence 
of death and recurrent myocardial infarction during the 
follow-up eriod (12% vs. 15%, p = 0.73). 
The principal findings of this study are that Holter mon- 
itoring detected ST segment depression after acute myocar- 
dial infarction in 32% of patients; this incidence was unrc- 
lated to the use of thrombolytic therapy. Patients with ST 
depression had more severe stenosis in the infarct-related 
artery, greater left ventricular dysfunction and a more unfa- 
vorable prognosis. The occurrence of ST depressiun on 
Holter monitoring was more closely related to the severity of 
residual stenosis in the infarct-related artery and to the 
incidence of cardiac events during follow-up than was the 
occurrence of ST segme ression during exercise test- 
ing. 
Relation between ST segment depression a  nosis. 
Our findings support he previously reported prognostic 
significance of ST segment depression after myocardial 
infarction (1,2,5). The novel conrribution ofour study is the 
identification f a possible pathophysiologic mechanism link- 
ing the occurrence ofST depression and unfavorable prog- 
nosis. Our study is the first to establish the association 
between the occurrence of ST segment depression after 
myocardial infarction and the severity of lumen arrowing in
the infarct-related artery. We also demonstrate a relation 
between ST segment depression a d lack of improvement i  
left ventricular function. ST segment depression was found 
more frequently among patients with anterior myocardial 
infarction, raising the possibility that greater left ventricular 
dysfunction was responsible for the occurrence of ST de- 
pression in these patients. However, analysis of covariance 
did not reveal a significant interaction between the site of 
infarction and occurrence ofST depression, suggesting that 
the occurrence ofST depression was unrelated tothe site of 
infarction. Furthermore, there was no difference in left 
ventricular function on day 1 between patients with and 
without ST segment depression, suggesting that he extent of 
initial left ventricular dysfunction was similar in patients 
with and without ST depression  Holter monitoring, which 
was performed on days 4 and 7. Thus, the lack of improve- 
ment in left ventricular function from day 1 to day 9 may be 
linked to the residual high grade stenosis in the infarct- 
related artery, which results in more frequent myocardial 
ischemia s detected by ST segment depression on Holter 
monitoring and persistent left ventricular dysfunction. 
Comparison with previous tudies. Gottlieb et al. (1) 
studied 103 patients convalescing from myocardial infarction 
who were preselected on the basis of an ejection fraction 
540% and were also part of an entiarrhythmic therapy trial. 
Although they found a similar frequency of ST shift (29%), 
the incidence of reh farction and death was more frequent in 
their report han ir our study; this difference most likely 
reflects their preselection f patients with a lower ejection 
fraction. Although patients with as compared with those 
without ST shift had more frequent events in that study (1), 
no difference in global ejection fraction was detected, and 
with and without ST depression. 
among patients with silent ischemia (2). 
Using Holter monitoring, Tzivoni et al. (5) performed a 
retrospective analysis 24 months aft ocardial infarction 
in 224 patients: hence, their p was more repre- 
sentative ofthose with stable ry disease than of 
patients with recent myocardial infarction. Furthermore, 
only 23% aftheir patients had Holter monitoring as a routine 
investigation with the remainder undergoing Holter monitor- 
ing for clinical indications, uch as assessment of antiar- 
rhythmic therapy, palpitation or chest pain. ST se 
depression was found in one third of 
follow-up eriod of 28 months, these patients had a greater 
incidence of death or recurrent myoc ial infarction. More 
important, ST segment depression on lter monitoring was 
predictive of unfavorable outcome inckpendent ofexercise 
residual stenosis i 
significance of Holter-detected ST segment shift in our 
patients did not apply to in-hospital events but only to those 
after hospital discharge. This result may have been influ- 
enced by early, in-hospital revascularization. However, our 
data in concert with the aforementioned three studies (1,2,.‘ ) 
confirm the prognostic significance of ST depression i  
patients after myocardial infarction. With the recent wide- 
spread use of thrombolytic therapy in patients with acute 
myocardial infarction, the prognostic mplications ofrecur- 
rent myocardial ischemia re of additional interest. We 
found no significant difference in the incidence of ST seg- 
ecause the greatest 
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